Joshua Schechter's Trading History
| LFCRLifecore Biomedical | Jun 05, 2026 | Director | Uninformative Buy | ― | $851.71K | |
| BRNBarnwell | Dec 04, 2025 | Director | Uninformative Buy | ― | $72.96K | |
| PRSUPursuit Attractions and Hospitality | Nov 12, 2025 | Director | Informative Buy | 34.00K | $3.14M | |
| BBBYQBed Bath & Beyond | Jan 24, 2023 | ― | Uninformative Sell | ― | $2.74K | |
| VIPVulcan Infrastructure and Power | Sep 15, 2021 | Director | Uninformative Sell | ― | $0.00 | |
| GCOGenesco | Jun 28, 2018 | Director | Uninformative Buy | ― | $93.71K | |
| PTRYThe Pantry | Mar 16, 2015 | ― | Uninformative Sell | ― | ― | |
| HNHHandy & Harman Ltd | ― | ― | ― | $0.00 | ||
| EGYVaalco Energy | ― | See Explanation of Responses, Ten Percent Owner | ― | $0.00 | ||
| SUNWQSunworks | ― | Director | ― | ― |
You May Also Like
Joshua Schechter insider profile FAQ
What is the percentage of profitable transactions made by Joshua Schechter?
The percentage of profitable transactions made by Joshua Schechter is 54%.
What is the average return per transaction made by Joshua Schechter?
The average return per transaction made by Joshua Schechter is 10.50%.
What stocks does Joshua Schechter hold?
Joshua Schechter holds: LFCR, BRN, BBBYQ, GCO, PRSU, SUNWQ, VIP, PTRY, EGY, HNH stocks.
What was Joshua Schechter's most profitable transaction?
Joshua Schechter’s most profitable transaction was an Informative Buy of PRSU stock on August 18, 2020. The return on the trade was 137.00%.
What is Joshua Schechter's role in Lifecore Biomedical?
Joshua Schechter's role in Lifecore Biomedical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.